ODAC Calls For Tougher Standards For Accelerated Approval In Oncology
Sponsors Withdraw Indications for Iressa, Celebrex
Doroshow: NCI Leaves It Up to Groups To Make Their Own Merger Deals
White House Yet To Name NCAB, Cancer Panel Members
NCI Largely Unaffected By NIH Translational Research Center
Trending Stories
- U.S. News rankings for cancer hospitals shift again with inclusion of Medicare Advantage data
Rankings now include a list of Best Regional Hospitals for Equitable Access - How Beth Carner went from six weeks left to live with stage 4 colon cancer to complete remission
- Robert Gallo named founding director of Microbial Oncology Program at TGH Cancer Institute
- Cancer Moonshot contributes additional $100M to reduce cancer burden in Africa
- A view from the BMT unit on the day a Russian cruise missile hit Kyiv’s Ohmatdyt hospital
- Proposed rule by CMS would expand access to cancer treatment at tribal facilities